PET probe-guided surgery

Journal of Surgical Oncology

Volumn 96, Issue 4, 2007, Pages 353-357

  Gulec, Seza A ^a,b  

^a Goshen Health System   (United States)

^b Center for Cancer Care   (United States)

Author keywords

Gamma probe; Recurrent metastatic lesions; Target to background ratio

Indexed keywords

GAMMA RADIATION; HUMAN; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; REVIEW; SCINTILLATION PROBE; SURGICAL TECHNIQUE; TREATMENT INDICATION; CLINICAL TRIAL; COMPUTER ASSISTED SURGERY; NEOPLASM; RADIOIMMUNOASSAY; SCINTILLATION CAMERA; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

CLINICAL TRIALS; FLUORODEOXYGLUCOSE F18; GAMMA CAMERAS; HUMANS; IODINE RADIOISOTOPES; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOIMMUNODETECTION; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SURGERY, COMPUTER-ASSISTED;

EID: 34848857069     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20862     Document Type: Review

References (23)

1. Gulec SA, Moffat FL, Carrol RG: The expanding clinical role for intraoperative gamma probes. Philadelphia: Lippincott-Raven Publishers 1997.
2. Moffat FL, Jr., Vargas-Cuba RD, Serafini AN, et al.: Preoperative scintigraphy and operative probe scintimetry of colorectal carcinoma using technetium-99m-88 BV59. J Nucl Med 1995; 36:738-745.
3. Krag DN, Meijer SJ, Weaver DL, et al.: Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-658.
4. Gulec SA, Moffat FL, Carroll RG, et al.: Sentinel lymph node localization in early breast cancer. J Nucl Med 1998;39:1388-1393.
5. Gulec SA, Moffat FL, Carroll RG, et al.: Gamma probe guided sentinel node biopsy in breast cancer. Q J Nucl Med 1997;41: 251-261.
6. Bozkurt MF, Ugur O, Hamaloglu E, et al.: Optimization of the gamma probe-guided parathyroidectomy. Am Surg 2003;69:720-725.
7. Mariant G, Gulec SA, Rubello D, et al.: Preoperative localization and radioguided parathyroid surgery. J Nucl Med 2003;44:1443-1458.
8. Schirmer WJ, O'dorisio TM, Schirmer TP, et al.: Intraoperative localization of neuroendocrine tumors with 125I-TYR(3)-octreotide and a hand-held gamma-detecting probe. Surgery 1993;114: 745-751.
9. Ahlman H, Tisell LE, Wangberg B, et al.: Somatostatin receptors on neuroendocrine tumors - a way to intraoperative diagnosis and localization. Yale J Biol Med 1994;67:215-221.
10. Gulec SA: A surgical perspective on positron emission tomography. J Surg Oncol 2007.
11. Gulec SA, Daghighian F, Essner R: PET-Probe: Evaluation of technical performance and clinical utility of a handheld high-energy gamma probe in oncologic surgery. Ann Surg Oncol 2006.
12. Gulec SA, Hoenie E, Hostetter R, et al.: PET probe guided surgery: Applications and clinical protocol. W J Surg Oncol 2007; 5:65.
13. Gulec SA, Mountcastle TS, Frey D, et al.: Cytoreductive surgery in patients with advanced-stage carcinoid tumors. Am Surg 2002;68:667-671.
14. Touzios JG, Kiely JM, Pitt SC, et al.: Neuroendocrine hepatic metastases: Does aggressive management improve survival? Ann Surg 2005;241:776-783.
15. Fuzun M, Terzi C, Sokmen S, et al.: Potentially curative resection for locoregional recurrence of colorectal cancer. Surg Today 2004;34:907-912.
16. Elias D, Liberale G, Vernerey D, et al.: Hepatic and extrahepatic colorectal metastases: When resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 2005;12:900-909.
17. Hsueh EC, Essner R, Foshag LJ, et al.: Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine. J Clin Oncol 2002;20:4549-4554.
18. Boerner AR, Weckesser M, Herzog H, et al.: Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med 1999;26:226-230.
19. Kuker RA, Mesoloras G, Gulec SA: Optimization of FDG-PET/CT imaging protocol for evaluation of patients with primary and metastatic liver disease. Int Semin Surg Oncol 2007;4:17.
20. Muehllrhner G, Karp JS, Surti S: Design considerations for PET scanners. Q J Nucl Med 2002;46:16-23.
21. Cobben DC, Jager PL, Elsinga PH, et al.: 3′-18F-fluoro-3′- deoxy-L-thymidine: A new tracer for staging metastatic melanoma? J Nucl Med 2003;44:1927-1932.
22. DeGrado TR, Baldwin SW, Wang S, et al.: Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. J Nucl Med 2001;42:1805-1814.
23. Rufini V, Calcagni ML, Baum RP: Imaging of neuroendocrine tumors. Semin Nucl Med 2006;36:228-247.